GRAIL Will Be Listed And Commence Regular-Way Trading On The Nasdaq Under The Symbol "GRAL" As Of June 25, 2024.

Benzinga · Jun 25 04:08

Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25

GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology

GRAIL, Inc. (NASDAQ:GRAL, formerly GRAIL, LLC))))), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ:ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol "GRAL" as of tomorrow, June 25, 2024.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

GRAIL Will Be Listed And Commence Regular-Way Trading On The Nasdaq Under The Symbol "GRAL" As Of June 25, 2024.

Risk Disclaimer